Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 14, 2024

Relationship Between Galectin-3 Blood Concentrations and Development of Post-COVID Syndrome

Respiratory Medicine


Additional Info

Respiratory Medicine
Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development?
Respir Med 2024 May 01;226(xx)107628, A Portacci, M Amendolara, VN Quaranta, I Iorillo, E Buonamico, F Diaferia, S Quaranta, C Locorotondo, A Schirinzi, E Boniello, S Dragonieri, GE Carpagnano

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading